Royalty Pharma
在场
是其中之一......
Royalty Pharma 是一家在股票代码 RPRX (US) 下上市的公司。
涉及Royalty Pharma的并购和融资。
- Ecora Resources has announced the acquisition of Royalty Pharma (公布2024七月1号).
高管
查看带有其 35 名主要高管的组织结构图
Royalty Pharma 搜索最多的简介
- Pablo Legorreta, Chairman of the Board, Founder and Chief Executiv...
- Ted Love, Director
- David Hodgson, Director
高管在Royalty Pharma变化
- Molly Sawaya已作为Executive Vice President and Head of Human Capital加入公司 (新闻发布的2024七月24号).
- Germano Giuliani, Director, 已经离开公司 (新闻发布的2024六月18号).
创建提醒
跟踪 Royalty Pharma 的高管变动
健康
Royalty Pharma 拥有 1,982 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、UnitedHealthcare (美国(美洲)) 和 Siemens Healthineers (德国)。
Popular M&A news in 健康
- Neuronetics 已收购 Greenbrook TMS (公布2024十二月10号).
- Cleerly 刚刚宣布为 106 筹款数百万美元。 (公布2024十二月9号).
- Soda Health 刚刚宣布为 50 筹款数百万美元。 (公布2024十二月5号).
健康 行业的其他推荐联系人
消息
Royalty Pharma 的最新新闻稿
- Royalty Pharma Declares Third Quarter 2022 Dividend | Royalty Pharma
- Press Releases | Royalty Pharma
- Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022 | Royalty Pharma
- Royalty Pharma Agrees to Acquire Royalty Interest in Trelegy Ellipta From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million | Royalty Pharma
- Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million | Royalty Pharma
- Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference | Royalty Pharma
- Royalty Pharma to Present at the UBS Global Healthcare Conference 2022 | Royalty Pharma
- Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders | Royalty Pharma
- Royalty Pharma Announces Charitable Alliance with Mount Sinai | Royalty Pharma
- Royalty Pharma Reports First Quarter 2022 Results | Royalty Pharma
- View more press releases Close
通过电子邮件
